Snibe Co., Ltd. receives the FDA clearance on the commercialization of TSH on Maglumi 2000 fully-automatic chemiluminescence immunoassay system (US FDA 510 (k), K NO.: K162698). It is the first company in China who received FDA cleared on CLIA product.


10 Diagnostic Imaging Trends for 2018

Best of 2017 Medical

 

Digital version